Research Article
Irisin Contributes to the Hepatoprotection of Dexmedetomidine during Intestinal Ischemia/Reperfusion
Figure 2
Dexmedetomidine improved serum DAO and liver dysfunction. Dexmedetomidine treatment decreased (a) DAO, (b) ALT, (c) AST, and (d) LDH levels and improved intestinal I/R-induced liver dysfunction. The results were presented as the deviation (; , vs. sham group; ; vs. I/R group; vs. I/R+Dex1 group).
(a) |
(b) |
(c) |
(d) |